GNLX
Q3 2026 EPS Estimate
$-0.20
Reports before open
FY2029E EPS$0.71
FY2030E EPS$1.52

Analyst Sentiment

Wall St. Consensus
Buy
3 analysts·Low coverage
67
Score
2 Buy (67%)1 Hold (33%)0 Sell (0%)
Rating Breakdown
Strong Buy
00%
Buy
267%
Hold
133%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$16.00
+447.0%
Consensus
$16.00
+447.0%
Bull
$20.00
+583.8%
12-Month Target Range3 analysts
$16.00$16.00$20.00
Current $2.92Consensus
Current Price
$2.92
Upside to Consensus
$13.07

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+359.73%
EPS
FY2028
Rev+619.97%
EPS
FY2029
Rev+114.52%
EPS

Earnings Surprises

Recent Analyst Actions

Oct 21, 2025Maxim Group
Genelux price target raised to $20 from $10 at Maxim
Target:$20.00
+199.9%from $6.67
Oct 21, 2025Lake Street
Genelux initiated with a Buy at Lake Street
Target:$16.00
+151.9%from $6.35
Oct 21, 2025Loop Capital Markets
Lake Street Capital Markets Starts Genelux Corp. (GNLX) at Buy
Target:$16.00
+151.9%from $6.35